TickerFactsScreenerDevelopers

AIM ImmunoTech Inc. (AIM) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2012: $44.70M2013: $29.30M2014: $25.00M2015: $20.37M2016: $15.50M2017: $8.70M2018: $5.58M2019: $13.44M2020: $61.29M2021: $56.88M2022: $38.47M2023: $10.23M2024: -$1.32M2025: -$9.78M-$9.78M
2012Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$9.78M-640.0%
2024-$1.32M-112.9%
2023$10.23M-73.4%
2022$38.47M-32.4%
2021$56.88M-7.2%
2020$61.29M+356.0%
2019$13.44M+140.9%
2018$5.58M-35.9%
2017$8.70M-43.8%
2016$15.50M-23.9%
2015$20.37M-18.5%
2014$25.00M-14.7%
2013$29.30M-34.5%
2012$44.70M—